cefuroxime has been researched along with Anemia, Splenic in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinca, A | 1 |
| Di Palma, A | 1 |
| Soriani, S | 1 |
| Sprocati, M | 1 |
| Mannella, P | 1 |
| Georgacopulo, P | 1 |
| Bagni, B | 1 |
| Vullo, C | 1 |
1 other study available for cefuroxime and Anemia, Splenic
| Article | Year |
|---|---|
Effectiveness of partial splenic embolization as treatment for hypersplenism in thalassaemia major: a 7-year follow up.
Topics: Adolescent; Adult; Ampicillin; beta-Thalassemia; Cefuroxime; Child; Embolization, Therapeutic; Femal | 1992 |